Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
65 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Britanico
Buenos Aires, Argentina
Luciana Bella QueroRecruiting - Cemic
CABA, Argentina
Julieta GrasselliRecruiting - Sanatorio de la Mujer
Rosario, Argentina
Withdrawn
- St Vincent'S Hospital Sydney - the Kinghorn Cancer Centre
Sydney, New South Wales, Australia
Hao-Wen SimRecruiting - Alfred Health, Medical Oncology Unit, Second Floor William Buckland Radiotherapy Center
Melbourne, Victoria, Australia
Sanjeev GillRecruiting - St John of God Subiaco Hospital
Subiaco, Western Australia, Australia
Recruiting
- Instituto Do Cancer Do Estado de Sao Paulo
Cerqueira César, Brazil
Camila Motta Venchiarutti MonizRecruiting - Hospital Erasto Gaertner
Curitiba, Brazil
Andressa RibasRecruiting - Iop - Instituto de Oncologia Do Parana
Curitiba, Brazil
Luciano Semensato BielaRecruiting - Hospital de Base de Sao Jose Do Rio Preto
São José do Rio Preto, Brazil
Kathia Cristina AbadallaRecruiting - Fundacao Antonio Prudente - A.C.Camargo Cancer Center
São Paulo, Brazil
Tiago FelisminoRecruiting
- Grand River Hospital - Grand River Regional Cancer Centre (grrcc)
Kitchener, OH, Canada
Recruiting - Sunnybrook Health Sciences Center
Toronto, OH, Canada
Recruiting - University of Toronto
Toronto, OH, Canada
Recruiting - Mcgill University Health Center
Montreal, Quebec, Canada
Recruiting
- Guangdong Provincial People'S Hospitall
Guangzhou, Guangdong, China
Dong MaRecruiting - Harbin Medical University - Cancer Hospital
Harbin, Heilongjiang, China
Yuxian BaiRecruiting - Jiangsu Provance Hospital
Nanjing, Jiangsu, China
Recruiting - Jilin Cancer Hospital
Changchun, Jilin, China
Ying ChengRecruiting - Shandong University - Shandong Cancer Hospital
Jinan, Shandong, China
Qi DangRecruiting - Zhongahan Hospital Fudan Unversity
Shanghai, Shanghai Municipality, China
Not, yet, recruiting - West China Hospital- Sichuan University
Chengdu, Sichuan, China
Dan CaoRecruiting - Sir Run Run Shaw Hospital, Zhejiang University
Hangzhou, Zhejiang, China
Hongming PanRecruiting - Shanghai Gobroad Cancer Hospital China Pharmaceutical University
Shanghai, China
Jin LiRecruiting - Tongji University Shanghai East Hospital
Shanghai, China
Recruiting
- the University of Hong Kong
Hong Kong Island, Hong Kong
Recruiting - the Chinese University of Hong Kong Prince of Wales Hospital
New Territories, Hong Kong
Recruiting
- Policlinico S. Orsola-Malpighi
Bologna, Italy
Giovanni BrandiRecruiting - Irccs Humanitas Research Hospital
Rozzano, Italy
Lorenza RimassaRecruiting - Aoui Verona - Ospedale Borgo Roma
Verona, Italy
Davide MelisiRecruiting
- Tohoku University Hospital
Sendai, Miyagi, Japan
Withdrawn - National Cancer Center Hospital East
Kashiwa-Shi, Japan
Susumu WatanabeRecruiting - Nagasaki University Hospital
Nagasaki, Japan
Withdrawn - Nagoya University Hospital
Nagoya, Japan
Takashi MizunoRecruiting - Osaka Metropolitan University Hospital
Osaka-Fu, Japan
Hiroji ShinkawaRecruiting
- Szpital Wojewdzki W Koszalinie Im. Mikoaja Kopernika
Koszalin, Poland
Withdrawn - Centrum Onkologii Ziemi Lubelskiej Im. W. Jana Z Dukli
Lublin, Poland
Withdrawn - Europejskie Centrum Zdrowia Otwock Sp. Z.O.O.
Otwock, Poland
Cezary SzcylikRecruiting - Centrum Onkologii-Instytut Im. Marii Skłodowskiej - Curie
Warsaw, Poland
Lucjan WyrwiczRecruiting
- Centro Hospitalar Lisboa Norte Chln Epe - Hospital de Santa Maria
Lisbon, Portugal
Withdrawn
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jul 2023
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 26 Jun 2026
- Registered enrollment
- 120
- Registry id
- NCT05727176
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.